Rhythm Pharmaceuticals (RYTM) Debt Ratio (2016 - 2026)

Rhythm Pharmaceuticals (RYTM) has 6 years of Debt Ratio data on file, last reported at 0.25 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.25, down 13.42% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.25 (down 13.42% YoY), and the FY2025 annual result was 0.23, down 19.52% from the prior year.
• Debt Ratio improved to 0.25 in Q1 2026 per RYTM's latest filing, from 0.23 in the prior quarter.
• Over five years, Debt Ratio peaked at 0.32 in Q4 2023 and troughed at 0.21 in Q3 2025.
• A 4-year average of 0.27 and a median of 0.28 in 2024 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2024 and 2025: Debt Ratio declined 12.24% in 2024, then declined 19.52% in 2025.
• A 4-year view of Debt Ratio shows it stood at 0.32 in 2023, then fell by 12.24% to 0.28 in 2024, then fell by 19.52% to 0.23 in 2025, then gained by 8.85% to 0.25 in 2026.
• Business Quant data shows RYTM's Debt Ratio at 0.25 in Q1 2026, 0.23 in Q4 2025, and 0.21 in Q3 2025.